Fig. 1From: Definitive radiotherapy alone over 60 Gy for patients unfit for combined treatment to stage II-III non-small cell lung cancer: retrospective analysis a Overall survival outcomes in the study patients. At 2 and 3 years these were estimated at 39 % and 23 %, respectively. b Progression-free survival outcomes in the study patients. The rates at 2 and 3 years were 23 % and 17 %, respectivelyBack to article page